Facebook Linkedin Twitter
Inside Precision Medicine Clinical Trial Shows Synthetic THC Reduces Agitation in Alzheimer’s Disease

Pharmacology

3d rendering of cannabis leaves, cannabis oil, and a dronabinol molecule, synthetic THC
News & Features

Clinical Trial Shows Synthetic THC Reduces Agitation in Alzheimer’s Disease

0
Human heart
News & Features

Anti-Inflammatory Marker Holds Promise for Cardiovascular Vaccine

Anita Chakraverty
0
Tau protein in Alzheimer's disease, illustration
News & Features

New Drug Candidate Works to Inhibit Both Tau Protein “Hotspots” in Alzheimer’s Disease

0
Low grade ductal carcinoma with positive estrogen receptor
News & Features

Estrogens Linked to Tumor Growth and Immune Suppression in Multiple Cancers

0
brain tumor
News & Features

Scientists Discover a Preventative Approach for Brain Metastasis

Alice McCarthy
0
Breast cancer cells
Informatics

Owkin and AstraZeneca Partner on AI-Powered gBRCA Screening for Breast Cancer

0
CAR T cell immunotherapy, illustration
News & Features

Outpatient CAR T Therapy Is Safe and Effective in Community Setting

0
Gloved hand holding COVID-19 vaccine such as the mRNA vaccine developed by Arcturus Therapeutics in syringe on a background of SARS-CoV-2 particles
Coronavirus

Arcturus’ COVID-19 Vaccine Triggers Enhanced Immune Response

0
DNA Molecular Structure
Molecular Dx

Genialis Launches krasID, a First in KRAS Inhibitor Testing for Drug Development

0
The infection is spreading
Coronavirus

Know Thy Enemy: MeMed’s Diagnostic Reduces Antibiotic Overuse in U.S. Trial

Jonathan D. Grinstein, PhD
0
123...173Page 1 of 173

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine